Literature DB >> 19046483

Intact sensorimotor gating in adult attention deficit hyperactivity disorder.

Mary-Claire Hanlon1, Frini Karayanidis, Ulrich Schall.   

Abstract

Disrupted sensorimotor gating has been found in various neuropsychiatric conditions which are characterized by impaired attention, poor impulse control, dysfunctional dopamine neurotransmission, and neurodevelopmental deficits. We investigated sensorimotor gating by prepulse inhibition (PPI) of the acoustic startle eyeblink reflex in 23 young adults diagnosed with attention deficit hyperactivity disorder (ADHD) as children and still symptomatic at the time of testing and 29 age-matched healthy control subjects. Sensorimotor gating was assessed in a passive listening task at prepulse-to-startle probe intervals of 30, 60, 120, 240, and 480 ms, and subsequently at prepulse-to-startle probe intervals of 60, 120, 240, and 480 ms whilst participants were performing a two-tone auditory discrimination task on the prepulse. Consistent with increased neural maturity and partially remitted symptomatology, our results indicate intact sensorimotor gating for both tasks in adult ADHD with no comorbidity, independent of the subjects' gender and whether ADHD subjects were receiving ongoing stimulant treatment or not. Reduced PPI at 120-ms lead intervals, on the other hand, was recorded in a subset of 10 ADHD subjects who were taken off their prescribed regular stimulants for 24 h and tested in a randomized counterbalanced order for on vs. off medication. However, our data remained inconclusive as to whether this observation constitutes beneficial treatment or acute stimulant withdrawal effects on sensorimotor gating.

Entities:  

Mesh:

Year:  2008        PMID: 19046483     DOI: 10.1017/S1461145708009711

Source DB:  PubMed          Journal:  Int J Neuropsychopharmacol        ISSN: 1461-1457            Impact factor:   5.176


  8 in total

1.  Methylphenidate enhances prepulse inhibition during processing of task-relevant stimuli in attention-deficit/hyperactivity disorder.

Authors:  Rebecca L Ashare; Larry W Hawk; Keri Shiels; Jessica D Rhodes; William E Pelham; James G Waxmonsky
Journal:  Psychophysiology       Date:  2010-03-10       Impact factor: 4.016

Review 2.  Genetic targeting of the amphetamine and methylphenidate-sensitive dopamine transporter: on the path to an animal model of attention-deficit hyperactivity disorder.

Authors:  Marc A Mergy; Raajaram Gowrishankar; Gwynne L Davis; Tammy N Jessen; Jane Wright; Gregg D Stanwood; Maureen K Hahn; Randy D Blakely
Journal:  Neurochem Int       Date:  2013-12-08       Impact factor: 3.921

3.  Sensorimotor gating deficits in schizophrenia: Advancing our understanding of the phenotype, its neural circuitry and genetic substrates.

Authors:  Neal R Swerdlow; Gregory A Light
Journal:  Schizophr Res       Date:  2018-03-07       Impact factor: 4.939

4.  Differential Pharmacological Regulation of Sensorimotor Gating Deficit in CB1 Knockout Mice and Associated Neurochemical and Histological Alterations.

Authors:  Antonio Ortega-Álvaro; Francisco Navarrete; Auxiliadora Aracil-Fernández; Daniela Navarro; Pere Berbel; Jorge Manzanares
Journal:  Neuropsychopharmacology       Date:  2015-04-21       Impact factor: 7.853

5.  Noise benefit in prepulse inhibition of the acoustic startle reflex.

Authors:  Erik Pålsson; Göran Söderlund; Daniel Klamer; Filip Bergquist
Journal:  Psychopharmacology (Berl)       Date:  2010-11-25       Impact factor: 4.530

6.  Affective modulation of the startle eyeblink and postauricular reflexes in autism spectrum disorder.

Authors:  Gabriel S Dichter; Stephen D Benning; Tia N Holtzclaw; James W Bodfish
Journal:  J Autism Dev Disord       Date:  2010-07

7.  Project DyAdd: classical eyeblink conditioning in adults with dyslexia and ADHD.

Authors:  Marja Laasonen; Jenni Kauppinen; Sami Leppämäki; Pekka Tani; Hanna Harno; Laura Hokkanen; Jan Wikgren
Journal:  Exp Brain Res       Date:  2012-09-05       Impact factor: 1.972

8.  Prepulse inhibition of startle response: recent advances in human studies of psychiatric disease.

Authors:  Hidetoshi Takahashi; Ryota Hashimoto; Masao Iwase; Ryouhei Ishii; Yoko Kamio; Masatoshi Takeda
Journal:  Clin Psychopharmacol Neurosci       Date:  2011-12-31       Impact factor: 2.582

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.